Tenet Healthcare (THC) Director Vineeta Agarwala Receives RSU Award

What Happened

• Vineeta Agarwala, a Director of Tenet Healthcare Corporation (THC), received a grant of 1,188 restricted stock units (RSUs) on 2026-05-27. The Form 4 reports the award as 1,188 derivative shares with an acquisition price of $0.00 (award/grant), so there was no cash purchase or sale.
• These RSUs are classified as derivative awards (not immediate common shares) and the reported grant value on the Form 4 is $0 at grant.

Key Details

• Transaction date: 2026-05-27; Form 4 filed 2026-05-28 (timely filing).
• Transaction type/code: Award/Grant (A) — 1,188 RSUs @ $0.00.
• Shares owned after transaction: Not specified in the provided summary (check the full Form 4 for total holdings).
• Footnote: RSUs granted under the Company’s Stock Incentive Plan; each RSU equals one share. RSUs vest on the first anniversary of the grant date. The reporting person may elect to receive up to 37% of the RSUs in cash in lieu of shares.

Context

• RSUs are a form of compensation that convert to shares only after vesting (here, one year). They do not represent an immediate buy or sell by the insider and therefore are not a direct market-confidence signal like an open-market purchase would be.
• The election to receive a portion in cash is a tax/settlement option and does not change the nature of the award. Check future filings for vesting-related transactions or any subsequent sales.